fingolimod hydrochloride has been researched along with Neutropenia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, K; Tanaka, K; Tanaka, M | 1 |
1 other study(ies) available for fingolimod hydrochloride and Neutropenia
| Article | Year |
|---|---|
Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropenia.
Topics: Adult; Aged; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lymphopenia; Multiple Sclerosis, Relapsing-Remitting; Neutropenia; Propylene Glycols; Sphingosine | 2013 |